64 related articles for article (PubMed ID: 8313315)
1. Hepatic arterial infusion pump chemotherapy combined with systemic chemotherapy for borderline resectable and unresectable colorectal liver metastases: phase II feasibility study.
Krul MF; Kok NFM; Osmani H; Buisman FE; Groot Koerkamp B; Grunhagen DJ; Verhoef C; Mostert B; Snaebjornsson P; Westerink B; Klompenhouwer EG; Donswijk ML; Ruers TJM; Douma JAJ; van Blijderveen N; Kingham TP; D'Angelica MI; Kemeny NE; Bolhuis K; Buffart TE; Kuhlmann KFD
Br J Surg; 2024 Apr; 111(4):. PubMed ID: 38608150
[TBL] [Abstract][Full Text] [Related]
2. Hepatic artery infusion pump for unresectable colorectal liver metastases before living donor liver transplant: Oncological friend or technical foe?
Goldaracena N; Zhu A; Vargas PA; Karanicolas P; Henry Z; Sayed BA; Cattral M; Rajendran L; Ghanekar A; Sapisochin G
Liver Transpl; 2024 May; ():. PubMed ID: 38727619
[No Abstract] [Full Text] [Related]
3. Colorectal hepatic metastasis: Evolving therapies.
Macedo FI; Makarawo T
World J Hepatol; 2014 Jul; 6(7):453-63. PubMed ID: 25067997
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of hepatectomy after hepatic arterial infusion chemotherapy for initially unresectable hepatic colorectal metastases.
Fujimoto Y; Akasu T; Yamamoto S; Fujita S; Moriya Y
J Gastrointest Surg; 2009 Sep; 13(9):1643-50. PubMed ID: 19582514
[TBL] [Abstract][Full Text] [Related]
5. Laparoscopic hepatic artery catheterization for regional chemotherapy: is this the best current option for liver metastatic disease?
Franklin M; Trevino J; Hernandez-Oaknin H; Fisher T; Berghoff K
Surg Endosc; 2006 Apr; 20(4):554-8. PubMed ID: 16508811
[TBL] [Abstract][Full Text] [Related]
6. Hepatic artery chemotherapy in the management of colorectal metastases.
Stratmann SL
Proc (Bayl Univ Med Cent); 2002 Oct; 15(4):376-9. PubMed ID: 16333468
[No Abstract] [Full Text] [Related]
7. True versus mild hyperthermia during isolated hepatic perfusion: effects on melphalan pharmacokinetics and liver function.
Pilati P; Mocellin S; Rossi CR; Ori C; Innocente F; Scalerta R; Ceccherini M; Da Pian PP; Nitti D; Lise M
World J Surg; 2004 Aug; 28(8):775-81. PubMed ID: 15457357
[TBL] [Abstract][Full Text] [Related]
8. Regional therapy of liver metastases.
Whisenant J; Venook A
Curr Treat Options Oncol; 2004 Oct; 5(5):427-37. PubMed ID: 15341680
[TBL] [Abstract][Full Text] [Related]
9. Liver regional continuous chemotherapy: use of femoral or subclavian artery for percutaneous implantation of catheter-port systems.
Zhu AL; Liu LX; Piao DX; Lin YX; Zhao JP; Jiang HC
World J Gastroenterol; 2004 Jun; 10(11):1659-62. PubMed ID: 15162545
[TBL] [Abstract][Full Text] [Related]
10. Complications of hepatic artery infusion: a review of 4580 reported cases.
Barnett KT; Malafa MP
Int J Gastrointest Cancer; 2001; 30(3):147-60. PubMed ID: 12540027
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic approaches to metastasis confined to the liver.
Venook AP; Warren RS
Curr Oncol Rep; 2001 Mar; 3(2):109-15. PubMed ID: 11177742
[TBL] [Abstract][Full Text] [Related]
12. Global approach to hepatic metastases from colorectal cancer: indication and outcome of intra-arterial chemotherapy and other hepatic-directed treatments.
Fiorentini G; Poddie DB; De Giorgi U; Guglielminetti D; Giovanis P; Leoni M; Latino W; Dazzi C; Cariello A; Turci D; Marangolo M
Med Oncol; 2000 Aug; 17(3):163-73. PubMed ID: 10962525
[TBL] [Abstract][Full Text] [Related]
13. [Penetrating duodenal ulcer as a complication of a hepatic artery port catheter in hepatic metastasis of sigmoid carcinoma].
Jäger D; Warzelhan J; Jäger E; Knuth A
Med Klin (Munich); 1997 Nov; 92(11):680-2. PubMed ID: 9480399
[TBL] [Abstract][Full Text] [Related]
14. Advanced and controlled drug delivery systems in clinical disease management.
Brouwers JR
Pharm World Sci; 1996 Oct; 18(5):153-62. PubMed ID: 8933575
[TBL] [Abstract][Full Text] [Related]
15. [What is the value of arterial chemotherapy in treatment of colorectal liver metastases].
Lorenz M; Encke A
Langenbecks Arch Chir; 1994; 379(6):317-20. PubMed ID: 7531267
[No Abstract] [Full Text] [Related]
16. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update.
Kemeny N; Seiter K; Conti JA; Cohen A; Bertino JR; Sigurdson ER; Botet J; Chapman D; Mazumdar M; Budd AJ
Cancer; 1994 Feb; 73(4):1134-42. PubMed ID: 8313315
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma.
Kemeny N; Conti JA; Cohen A; Campana P; Huang Y; Shi WJ; Botet J; Pulliam S; Bertino JR
J Clin Oncol; 1994 Nov; 12(11):2288-95. PubMed ID: 7964942
[TBL] [Abstract][Full Text] [Related]
18. Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinoma.
Kemeny N; Cohen A; Bertino JR; Sigurdson ER; Botet J; Oderman P
Cancer; 1990 Jun; 65(11):2446-50. PubMed ID: 2140070
[TBL] [Abstract][Full Text] [Related]
19. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.
Kemeny N; Eid A; Stockman J; Gonen M; Schwartz L; Tetzlaff E; Paty P
J Surg Oncol; 2005 Aug; 91(2):97-101. PubMed ID: 16028279
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
